Carlyle Genesis UK LLC's Net Worth

Estimate Recalculated Nov 1, 2024 11:27AM EST

Who is Carlyle Genesis UK LLC

Carlyle Genesis UK LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SOLENO THERAPEUTICS INC, Vera Therapeutics, Inc., Jasper Therapeutics, Inc., and eFFECTOR Therapeutics, Inc..

SEC CIK

Carlyle Genesis UK LLC's CIK is 0001941860

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SOLENO THERAPEUTICS INC

Investor

Updated Oct 02, 2023

View Quote Details


Form 4	—	—	$1.75	$1.91M	Oct 02, 2023	2.29M	Options	—	Sep 28
Form 4	—	2.87M	$0.44	$1.27M	May 10, 2023	2.87M	Purchase	—	May 08
Form 3	—	—	—	—	Aug 11, 2022	18.02M	—	—	—

Showing 3 results

Vera Therapeutics, Inc.

Investor

Updated Aug 19, 2022

View Quote Details


Form 4	-0.33%	-9.93K	$15.63	-$91.85K	Aug 19, 2022	2.96M	Sale	—	Aug 17
Form 3	—	—	—	—	Aug 11, 2022	2.96M	—	—	—

Showing 2 results

Jasper Therapeutics, Inc.

Investor

Updated Feb 12, 2024

View Quote Details


Form 4	21.68%	190.00K	$12.95	$2.46M	Feb 12, 2024	1.07M	Purchase	—	Feb 08
Form 4	55.67%	3.13M	$1.50	$4.70M	Jan 31, 2023	8.76M	Purchase	—	Jan 27
Form 3	—	—	—	—	Aug 11, 2022	5.63M	—	—	—

Showing 3 results

eFFECTOR Therapeutics, Inc.

Investor

Updated Aug 11, 2022

View Quote Details


Form 3	—	—	—	—	Aug 11, 2022	4.82M	—	—	—

Showing 1 results